Answers are grounded in this paper and cite their sources.
The question of whether a duty exists to recontact patients about new genetic information has been debated for decades without consensus, but new technologies compel us to reconsider this complex matter, weighing ethical, legal, and practical considerations.
No takes yet. Share an insight, caveat, or question.
Reed E. Pyeritz (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: